O’Melveny has advised Keymed Biosciences.Keymed Biosciences has completed a top-up placement valued at approximately US$108 million (about HK$854 million). The transaction involved a placement of 21,600,000…
Keymed Biosciences Completes US$108 Million Top-up Placement
